NCT05431569 2022-06-24A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung CancerMabwell (Shanghai) Bioscience Co., Ltd.Phase 2 Unknown36 enrolled